Retatrutide has shown similar side effects, as well as a prickling sensation known as dysesthesia
Scientific Background PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide under investigation for selective agonist activity at melanocortin receptors MC3R and MC4R
SupplySide Global 2025: Targeted solutions for womens health, longevity and GLP-1 complements At this years SupplySide Global 2025 in Las Vegas, Nevada, US, exhibitors highlighted targeted womens health solutions, solutions to meet the healthy longevity trend, and formulations for consumers using weight management medications, such as GLP-1 receptor agonists
Bank of America's checks on the Eucalyptus platform indicated that about 90% of revenue is expected from branded GLP-1 distribution, operating at roughly 40% gross margins